Uplizna is an FDA-approved treatment for adults with neuromyletis optica spectrum disorder who test positive for AQP4-IgG antibodies.| Neuromyelitis News
Uplizna safely provided sustained disease control for NMOSD patients, according to final data from a Phase 2/3 clinical trial.| Neuromyelitis News